Imaging the Cytosolic Drug Delivery Mechanism of HDL-Like Nanoparticles

ABSTRACTPurposeMolecular therapeutics often require an effective nanoparticle-based delivery strategy to transport them to cytosolic organelles to be functional. Recently, a cytosolic delivery strategy based on the scavenger receptor class B type I (SR-BI) mediated pathway has shown great potential for the effective delivery of theranostics agents into the cytoplasm of cells without detrimental endosomal entrapment. This study elucidates this unique delivery mechanism for improving cytosolic drug delivery.MethodsMultifluorophore-labeled HDL-mimicking peptide phospholipid scaffold (HPPS) nanoparticles were developed. Fluorescence imaging was utilized to examine HPPS transporting payloads into cells step by step through sequential inhibition studies.ResultsHPPS specifically recognizes and binds to SR-BI, then interacts with SR-BI, which results in direct transport of payload molecules into the cell cytoplasm without entire particles internalization. The cytosolic transport of payloads occurred through a temperature- and energy-independent pathway, and was also different from actin- and clathrin-mediated endocytosis. Furthermore, this transport was significantly inhibited by disruption of lipid rafts using filipin or methyl-β-cyclodextrin.ConclusionsThe cytosolic delivery of payloads by HPPS via SR-BI targeting is predominately mediated through a lipid rafts/caveolae-like pathway. This cytosolic delivery strategy can be utilized for transporting molecular therapeutics that require their action sites to be within cytosolic organelles to enhance therapeutic effect.

[1]  T. Kirchhausen,et al.  Endocytosis is not required for the selective lipid uptake mediated by murine SR-BI. , 2005, Biochimica et biophysica acta.

[2]  R. Temel,et al.  Mechanism of Scavenger Receptor Class B Type I-mediated Selective Uptake of Cholesteryl Esters from High Density Lipoprotein to Adrenal Cells* , 1999, The Journal of Biological Chemistry.

[3]  A. Lacko,et al.  High density lipoprotein complexes as delivery vehicles for anticancer drugs. , 2002, Anticancer research.

[4]  Heng Zhang,et al.  Biomimetic, synthetic HDL nanostructures for lymphoma , 2013, Proceedings of the National Academy of Sciences.

[5]  S. Carr,et al.  Exoplasmic cysteine Cys384 of the HDL receptor SR-BI is critical for its sensitivity to a small-molecule inhibitor and normal lipid transport activity , 2011, Proceedings of the National Academy of Sciences.

[6]  L. Ellis,et al.  Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles. , 2011, Neoplasia.

[7]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[8]  Helen H. Hobbs,et al.  Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.

[9]  S. Curley,et al.  Stability of antibody-conjugated gold nanoparticles in the endolysosomal nanoenvironment: implications for noninvasive radiofrequency-based cancer therapy. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[10]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[11]  Zahi A Fayad,et al.  Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. , 2004, Journal of the American Chemical Society.

[12]  Chad A Mirkin,et al.  Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery. , 2011, Nano letters.

[13]  F. Maxfield,et al.  Different transport routes for high density lipoprotein and its associated free sterol in polarized hepatic cellss⃞s⃞ The online version of this article (available at http://www.jlr.org) contains an additional two figures. Published, JLR Papers in Press, December 16, 2003. DOI 10.1194/jlr.M300440-JL , 2004, Journal of Lipid Research.

[14]  Mitsuru Akashi,et al.  Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[15]  R. McPherson,et al.  Scavenger receptor class B type I localizes to a late endosomal compartment These studies were supported by a grant from the Canadian Institutes for Health Research (CIHR) (to R.M.). Published, JLR Papers in Press, March 29, 2008. , 2008, Journal of Lipid Research.

[16]  T. Park,et al.  Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[17]  H Anholt,et al.  Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. , 1999, Cancer research.

[18]  Kai Simons,et al.  Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.

[19]  G. Schütz,et al.  SR-BI-mediated High Density Lipoprotein (HDL) Endocytosis Leads to HDL Resecretion Facilitating Cholesterol Efflux* , 2006, Journal of Biological Chemistry.

[20]  Astrid Gräslund,et al.  Mechanisms of Cellular Uptake of Cell-Penetrating Peptides , 2011, Journal of biophysics.

[21]  B. Masereel,et al.  An overview of inhibitors of Na(+)/H(+) exchanger. , 2003, European journal of medicinal chemistry.

[22]  M. Uesaka,et al.  Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. , 2011, Nature nanotechnology.

[23]  Honglin Jin,et al.  Attenuation of nontargeted cell-kill using a high-density lipoprotein-mimicking peptide--phospholipid nanoscaffold. , 2011, Nanomedicine.

[24]  P. Connell,et al.  The Class B, Type I Scavenger Receptor Promotes the Selective Uptake of High Density Lipoprotein Cholesterol Ethers into Caveolae* , 1999, The Journal of Biological Chemistry.

[25]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[26]  M. Krieger.  Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. , 1999, Annual review of biochemistry.

[27]  Zhihong Zhang,et al.  Efficient systemic delivery of siRNA by using high-density lipoprotein-mimicking peptide lipid nanoparticles. , 2012, Nanomedicine.

[28]  G. Hardee,et al.  Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes , 2003, Gene Therapy.

[29]  V. Labhasetwar,et al.  Biodegradable nanoparticles for cytosolic delivery of therapeutics. , 2007, Advanced drug delivery reviews.

[30]  A. Zimmer,et al.  Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Marsha Penman,et al.  Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Darrell J Irvine,et al.  Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. , 2007, Nano letters.

[33]  Shuming Nie,et al.  Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. , 2008, Journal of the American Chemical Society.

[34]  A. Tall,et al.  ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  I. Mellman,et al.  ATP and cytosol requirements for transferrin recycling in intact and disrupted MDCK cells. , 1990, The EMBO journal.

[36]  P. Oh,et al.  Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules , 1994, The Journal of cell biology.

[37]  L. Falstrault,et al.  Localization and regulation of SR-BI in membrane rafts of HepG2 cells , 2004, Journal of Cell Science.

[38]  Eric Vives,et al.  Cell-penetrating Peptides , 2003, The Journal of Biological Chemistry.

[39]  Samuel A Wickline,et al.  Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery. , 2008, Biomaterials.

[40]  Qingming Luo,et al.  Biomimetic nanocarrier for direct cytosolic drug delivery. , 2009, Angewandte Chemie.

[41]  K. Hahn,et al.  Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling , 2010, The Journal of cell biology.

[42]  Claudia Calcagno,et al.  Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. , 2008, Nano letters.

[43]  M. Connelly,et al.  Scavenger receptor BI (SR-BI) clustered on microvillar extensions suggests that this plasma membrane domain is a way station for cholesterol trafficking between cells and high-density lipoprotein. , 2003, Molecular biology of the cell.